• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Microbiologics Expands Virology Services

    ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies

    Executive Moves: Novavax

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion

    Catalent Biologics Completes Madison Expansion
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion

    Ensuring Pharma Manufacturing Quality

    Exploring ICP-MS expertise at Almac

    Catalent Biologics Completes Madison Expansion

    Ascendia Pharmaceuticals Poised for Expansion
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success

    Enteris BioPharma: Custom Solutions – From Bench to Market

    The Benefits of Outsourcing Cold Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Microbiologics Expands Virology Services

    ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion

    Exploring ICP-MS expertise at Almac

    Catalent Biologics Completes Madison Expansion
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Syngene

    Quotient Sciences

    Reed-Lane

    Almac Group
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Syngene

    PCI Pharma Services

    Alcami

    Almac Group

    Adare Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Like It’s 1999

    Reflecting on 20 years of Contract Pharma.

    Like It’s 1999
    Related CONTENT
    • Asymchem
    • Legacy Pharma Solutions
    • PCI Pharma Services
    • Catalent Pharma Solutions
    • Mogene
    Gil Roth, President, Pharma & Biopharma Outsourcing Association10.15.19
    The first time “20 years ago” resonated with me was in 1997, when I was driving to work and passed the movie theater where Star Wars was being re-released. In a flash, I remembered being a 6-year-old kid outside that same theater in 1977, waiting to get in to my first viewing of Star Wars. My old man recognized a pal of his near the front, which enabled us to cut in the line that stretched all the way around the back of the RKO. Since that flashback, the “20 years ago” moments came fast and furious, except with bigger numbers attached, until they segued into “back when I was young” anecdotes.

    But 20 years ago for the origin of Contract Pharma? That one packs a wallop.

    I still remember the afternoon my editorial director walked into my office to say, “I’ve got good news and bad news: the good news is that you don’t work for me anymore; the bad news is that we’re launching a new pharmaceutical magazine and you’re the editor,” and dropped a business plan on my desk.

    At that point, I was managing editor for a cosmetic packaging magazine, with no pharma experience to speak of. I didn’t know about drug manufacturing, outsourcing, clinical trials, formulation development or any of the other good stuff that this magazine would cover. And 1999 wasn’t exactly the golden age of the search engine, so it took a lot of work (with plenty of missteps) to build a ground-level understanding of the sector.

    Knowing so little about the pharma industry overall, I thought the customer side would be happy to talk about how outsourcing and contract manufacturing organizations (CMOs) were giving them a competitive edge in manufacturing, enabling them to focus on R&D and marketing. That lasted until I heard a variation of the same statement from five major pharma companies: “We make what we sell, and we sell what we make.” I knew it wasn’t true; I’d already been to visit [CMO X] and saw a lobby letter board reading, “Welcome, [MAJOR PHARMA COMPANY Y],” but I figured they had their reasons for not talking about their CMOs.

    So instead of working closely with the customer side to understand the dynamics of this industry, I had to talk to the CMOs. Which, you could say, led to the role I now hold, but we’ll get to that later.
    The business plan that was plopped on my desk (I still have it) was written by a pair of publishers from another magazine company who had the idea for Contract Pharma but wanted to make sure it was done right. The plan had in-depth market analysis, a strong list of prospective advertisers, sample editorial topics, a publishing schedule based on major industry trade shows, and multi-year revenue projections. Gary Durr and Damaris Kope had the vision for this magazine, and knew they could make it work.

    Then the editor they were going to bring with them got cold feet and they wound up with me.

    It’s to their enduring credit that they didn’t panic, insist on an editor with pharma-experience, or run back to their company and abort the concept. They were willing to take a chance on a 28-year-old weirdo (let’s be honest), and did their best to get me up to speed.

    I’m forever thankful to them for that, and for everything they taught me over the ~15 years I worked with them.

    The magazine exceeded all expectations in our first years, blasting past the revenue expectations as the ad pages kept coming in and I kept trying to figure out what all these companies DID, exactly. I was insecure enough at that point to believe that everyone else knew what all the acronyms and terminology meant, and that I was the clueless one in the industry. That went away after a few years, which is why we decided to make the annual Glossary of Terms, since it turns out NO ONE knows all this stuff.

    The first 5 or 6 issues were a one-man show, editorially speaking, but as the page counts grew, we brought on staff. Bringing aboard Sarah Madley, our first Associate Editor, helped me step back from some of the routine details of the magazine and try to plan ahead for what that was worth—given the occasional contributed article cancellations and “it seemed like a good topic at the time” ideas I had for staff-written articles. Having an associate also taught me that humans aren’t telepathic and it helps to actually tell them what you want.

    Sarah departed after a few years, and with the arrival of Kristin Brooks fifteen years ago, Contract Pharma really hit its stride. We produced strong editorial, built a can’t-miss conference (that began in 2002, and Kristin’s contributions have been essential to its growth), and cemented Contract Pharma’s position as the premier magazine in the outsourcing space. Kristin’s contributions have been immeasurable and the magazine couldn’t have succeeded without her. Over the years, the Contract Pharma team weathered the financial crash, waves of industry consolidation, and the transition to digital without sacrificing what made the magazine strong. (I also want to thank all the back-office staff at Rodman Media who played a role in the magazine’s success, from Production and Art to Circulation and Online, as well as the office managers, the boss, and my editorial director, who started this whole mess by dropping that plan on me in 1999.)

    It was with some trepidation and sadness that I left at the beginning of 2014 to launch the Pharma & Biopharma Outsourcing Association (PBOA). The idea for it came out of an article I wrote about the Generic Drug User Fee Amendments (GDUFA) in 2013. More than a dozen companies gave me quotes for that article, and every single one of them wanted to stay anonymous, for fear of reprisals with the agency. That’s when I got the idea that this industry needs a voice with FDA (and Congress, as it turns out), and that an association can be a lightning rod of sorts.

    But it wasn’t just a career opportunity for me. I formed PBOA because all those years of working with the CMO/CDMO sector—and I still remember the phone call where JJ Feik of DPT Labs told me we need to add a “D” to make it the CDMO sector, with a focus on development services—brought me up close not just to the companies and what they do for patients, but to the people they employ. I’ve been to some of their weddings and their kids’ graduations, and they’ve been there during some of my tough moments. I care about this sector and the people who work in it.

    Now that I’m running a trade association and registered with the feds as a lobbyist, I tell people that schmoozing is my mutant super-power, but I doubt I would have built all those close relationships without Gary and Damaris bringing me along to meetings and meals, and teaching me how to talk about something besides work (or modernist literature, as was my wont). I was insular, insecure, and aloof when I started out on this magazine, and I probably wouldn’t have taken the time to get to know people without the example they set. I thank them both for all the guidance that enabled me to make this jump. We went through a lot together, and I wish them luck on the next stage of their lives.

    For 20 years, Contract Pharma has championed the bio/pharma outsourcing sector, and the work it does to develop and manufacture medicines for patients in need. I’m honored and proud to have played a role in it. Here’s to another 20 years!


    Gil Roth
    President, Pharma & Biopharma Outsourcing Association

    Gil Roth is the President of the Pharma & Biopharma Outsourcing Association (pharma-bio.org), a nonprofit trade association advocating for the CMO/CDMO sector. He was the Founding Editor of Contract Pharma, serving from 1999 to 2014. He can be reached at gil.roth@pharma-bio.org
    Related Searches
    • Formulation Development
    • pharmaceutical magazine
    • Biopharma
    • CDMO
    Suggested For You
    Asymchem Asymchem
    Legacy Pharma Solutions Legacy Pharma Solutions
    PCI Pharma Services PCI Pharma Services
    Catalent Pharma Solutions Catalent Pharma Solutions
    Mogene Mogene
    Regis Custom Pharma Regis Custom Pharma
    Softweb Solutions Softweb Solutions
    Vetio Animal Health Vetio Animal Health
    Adare Pharma Solutions Adare Pharma Solutions
    CONTRACT PHARMA Adds Media Sales Directors CONTRACT PHARMA Adds Media Sales Directors
    Contract Pharma’s 20th Anniversary Retrospective: Drug Development  Contract Pharma’s 20th Anniversary Retrospective: Drug Development
    20 Year Retrospective 20 Year Retrospective
    Contract Pharma’s 20th Anniversary Retrospective Contract Pharma’s 20th Anniversary Retrospective
    VIDEO: Pharma Packaging Solutions VIDEO: Pharma Packaging Solutions' Scott Garverick
    VIDEO: CPL VIDEO: CPL's David Tyler

    Related Columns

    • Biologics, Proteins, Vaccines | Regulatory Affairs
      What Will Change at FDA for 2021?

      What Will Change at FDA for 2021?

      (R)evolution of the industry’s data, catalyzed by changes at FDA and what’s the likely impact to the pharmaceutical industry?
      Ben Locwin, Contributing Editor, International COVID-19 Advisor, Healthcare Futurist 04.01.21

    • Information Technology
      Life Sciences Strive for Greater Agility

      Life Sciences Strive for Greater Agility

      Embracing real-time drug safety monitoring during and post COVID will continue to propel the industry forward.
      Ronan Brown and Joe Rymsza, IQVIA 03.01.21

    • Biologics, Proteins, Vaccines
      Vaccines and Return-To-Normalcy

      Vaccines and Return-To-Normalcy

      Planning for a future in which COVID-19 won’t simply ‘disappear.’
      Ben Locwin, Contributing Editor 03.01.21


    • Chemistry | Laboratory Testing
      Back to the Future

      Back to the Future

      All that’s Old is New Again.
      Emil W. Ciurczak, DoraMaxx Consulting 03.01.21

    • Biologics, Proteins, Vaccines
      Vaccines 2021

      Vaccines 2021

      Looking at the behavioral economics of vaccinations.
      Ben Locwin, Contributing Editor 01.27.21

    • A Potential “Marriage”

      A Potential “Marriage”

      Initiator companies and generics/CMOs working together.
      Emil W. Ciurczak, DoraMaxx Consulting 11.17.20


    • When Politics and Science Collide

      When Politics and Science Collide

      COVID-19 illustrates why science should always be a principal informer of politics to make better and smarter decisions.
      Ben Locwin, Contributing Editor 11.17.20

    • The Pandemic’s Become an Insurmountable Opportunity

      The Pandemic’s Become an Insurmountable Opportunity

      Every Cloud has a Silver Lining(?)
      Emil W. Ciurczak, Contributing Editor 10.14.20

    • Biologics, Proteins, Vaccines
      It Takes a Vaccine… To End The Pandemic [У нас есть хорошая вакцина]

      It Takes a Vaccine… To End The Pandemic [У нас есть хорошая вакцина]

      Race for the vaccines is heating up.
      Ben Locwin, Contributing Editor 09.09.20


    • cGMP Manufacture
      Keys to Biotech Success

      Keys to Biotech Success

      Four steps emerging biotech companies can take to achieve success
      Thierry Cournez, Head of End-to-End Solutions, MilliporeSigma 06.04.20

    • Analytical Services
      What Happens When the All-Clear Signal is Given?

      What Happens When the All-Clear Signal is Given?

      Maybe 3M had some good ideas?
      Emil W. Ciurczak, DoraMaxx Consulting 06.04.20

    • Almost Like the Olympics:

      Almost Like the Olympics:

      “Smaller, Faster, Smarter”
      Emil W. Ciurczak, DoraMaxx Consulting 05.05.20


    • Rapid Delivery of Medical Countermeasures Amid Pandemic

      Rapid Delivery of Medical Countermeasures Amid Pandemic

      Robert Erwin of iBio discusses the company’s COVID-19 vaccine development efforts and FastPharming manufacturing platform for the rapid delivery of vaccines
      Kristin Brooks, Managing Editor, Contract Pharma 05.05.20

    • The Supply Chain House of Cards

      The Supply Chain House of Cards

      The COVID-19 pandemic exposes pressures on extended global supply chains
      Emil W. Ciurczak, DoraMaxx Consulting 04.01.20

    • Analytical Services | Laboratory Testing
      The Supply Chain, as Developed by IKEA (some assembly required)

      The Supply Chain, as Developed by IKEA (some assembly required)

      Pick One from Column A, Two from Column B, etc.
      Emil W. Ciurczak, DoraMaxx Consulting 03.04.20

    Trending
    • Astellas, Affinivax In Global MAPS Vax Pact
    • Ascendia Pharmaceuticals Poised For Expansion
    • Sanofi To Build New $700M Flu Vaccine Facility In Canada
    • Catalent Biologics Completes Madison Expansion
    • ANI Acquires Branded Products Portfolio From Sandoz
    Breaking News
    • Microbiologics Expands Virology Services
    • ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies
    • Executive Moves: Novavax
    • Albumedix Completes Commercial-Scale Mfg. Facility Expansion
    • Catalent Biologics Completes Madison Expansion
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study
    Review Covers Role of Vitamin K2 in the ‘Calcium Paradox’
    KD Pharma Acquires Rohner AG Manufacturing Assets
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    Shepherd Color Unveils Bismuth Vanadate Yellow Pigment
    HMG Paints Reports Positive Feedback on Contract Matt Emulsion
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Katena Acquires Ophthalmic Surgical Instrument Maker ASICO
    Vicarious Surgical Appoints CFO and Chief Legal Officer
    Nagarro Achieves ISO 13485 Certification
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Microbiologics Expands Virology Services
    ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies
    Executive Moves: Novavax
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Cosmoprof Worldwide Bologna Postpones 2021 Show
    Native Launches Broad Spectrum SPF 30 Mineral Sunscreens
    Revieve Launches Skin Coach
    Happi

    Latest Breaking News From Happi

    BASF Increases Price of Kaolin
    Kao Launches Online Beauty Store in Europe
    Neutrogena Takes Action on Skin Health Disparities
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Maxcess updates user interface for Fife guiding Sensor
    Bobst announces virtual packaging industry event
    Edale appoints agent in Poland
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    PFNonwovens Adding New Capabilities in Znojmo
    Russ Torres Named Group President of Kimberly-Clark North America
    Aries Face Masks Meet ASTM Standards
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Global Bone Tumor Ablation Devices Market to Top $111 Million by 2027
    GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations
    SUPERSMART Wins 'Best Publicly Funded Project Demonstrator' in 2021 OE-A Competition

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login